BRTX vs COP · rev $401.0K vs P/E 19, rev $58.94B
BioRestorative Therapies Inc (BRTX) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
BRTX currently screens at market cap $10.2M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the BRTX and COP stock pages for the full models.
Not investment advice.